Welcome to our dedicated page for National Health Investors news (Ticker: NHI), a resource for investors and traders seeking the latest updates and insights on National Health Investors stock.
National Health Investors, Inc. (NHI) provides essential updates for stakeholders tracking this healthcare-focused REIT. This page aggregates official announcements and strategic developments related to senior housing financing, medical facility transactions, and operational partnerships.
Investors and analysts will find timely updates on earnings reports, property acquisitions, and joint venture formations, along with regulatory filings and dividend declarations. The curated news flow emphasizes NHI's core activities in sale-leaseback transactions and specialty hospital financing.
Bookmark this page to monitor NHI's progress in capitalizing on aging population trends through its diversified portfolio of assisted living communities, memory care facilities, and skilled nursing properties. Check regularly for insights into how the company balances stable rental income with growth-oriented mezzanine financing strategies.
National Health Investors (NYSE:NHI) will release third-quarter results for the period ended September 30, 2025 after market close on Thursday, November 6, 2025. A conference call to discuss results is scheduled for Friday, November 7, 2025 at 10:00 a.m. ET. Participants can join by phone at (888) 506-0062 using access code 136615 or listen live online at www.nhireit.com and the webcast link provided.
The live broadcast will be replayed online shortly after the call and the replay will remain available for one year.
National Health Investors (NYSE:NHI) has acquired four senior housing properties for $74.3 million in Oklahoma and Oregon, adding 344 units to its Senior Housing Operating Portfolio (SHOP). The properties will be managed by existing partner Compass Senior Living and are expected to generate an initial yield of 7.5% after capital expenditures.
The acquisition was partially funded through the cancellation of a $9.5 million mortgage loan with an 8.5% interest rate. Year-to-date, NHI has completed investments totaling $249.2 million at an average initial yield of 8.0%. The company has additional signed LOIs worth $132.4 million and is evaluating an investment pipeline of approximately $278 million.
National Health Investors (NYSE:NHI) has priced a significant offering of $350 million Senior Notes due 2033. The notes will be issued at 98.903% of par value with a 5.350% coupon rate, with interest payable semi-annually starting February 1, 2026.
The offering, expected to close on September 26, 2025, will primarily be used to reduce borrowings under NHI's $700 million revolving credit facility. Additional proceeds will support working capital, acquisitions, mortgage investments, and debt repayment. J.P. Morgan, BofA Securities, and Wells Fargo Securities are among the joint book-running managers for this debt offering.
National Health Investors (NYSE:NHI), a healthcare real estate investment trust, has announced the release of an investor update available on their investor relations website. The update can be accessed through the presentations and webcasts section of their corporate website.
National Health Investors (NYSE:NHI) has announced its third quarter dividend payment for 2025. The company will distribute a dividend of $0.92 per common share to stockholders. The dividend will be paid on October 31, 2025, to shareholders of record as of September 30, 2025.
National Health Investors (NYSE:NHI) reported strong Q2 2025 results, exceeding expectations and leading to raised full-year guidance. The company achieved normalized FFO of $1.22 per diluted share, up from $1.18 in Q2 2024. Key highlights include:
The company completed significant portfolio changes, including the $63.5 million acquisition of six memory care communities and the transition of seven properties to their SHOP portfolio. Rental income increased 6.9% to $4.5 million, driven by new investments since June 2024.
NHI maintains a strong financial position with $1.1 billion in net debt and a favorable net debt to adjusted EBITDA ratio of 3.9x. The company updated its 2025 guidance, projecting normalized FFO per share of $4.78-$4.82 and normalized FAD of $227.9-$229.8 million.
National Health Investors (NYSE:NHI) has scheduled its second quarter 2025 earnings release and conference call. The company will release Q2 2025 financial results after market close on Wednesday, August 6, 2025.
A conference call to discuss the results will be held on Thursday, August 7, 2025, at 10:00 a.m. Eastern Time. Investors can participate via interactive teleconference at (888) 506-0062 using access code 494218. The call will also be available via live webcast on the company's website and will remain accessible for replay for one year.